证券代码：603810 证券简称：丰山集团 转债简称：113649 转债简称：丰山转债 | | 一、公司基本情况介绍 | | --- | --- | | | 二、沟通交流的主要问题： | | | 1、目前市场上三氯乙酰氯原材料情况如何？ | | | 答：据公司了解，目前宁夏及内蒙工厂尚未开工，原材料价格目 | | | 前仍维持在高位，导致相关产品价格维持在一季度水平。 | | | 2、公司产品价格走势如何？ | | | 答：公司产品价格二季度以来，与一季度相比基本保持平稳。 | | | 3、公司2025年产量规划大概情况是怎么样的？ | | | 答：公司农药板块主要产品线产能利用率处在高位运行。由于绿 | | | 草定市场需求持续增加，公司今年计划通过技改项目新增2000吨左右 | | | 的产能。 | | | 4、新能源业务的半固态电池电解液和钠电产品的销售情况如 | | | 何？ | | | 答：丰山全诺半固态电池电解液研发测试中,钠离子电池电解液 | | | 主要是向众钠等公司进行销售。 | | | 5、公司如何应对原材料成本波动风险？ | | | 答：通常按月招标采购原材料，针对个别产品波动，公司在研 ...

Group 1 - Dongfang Shenghong's controlling shareholder plans to increase its stake by 500 million to 1 billion yuan within six months [1] - Aiwei Electronics is set to mass-produce a low-power high-voltage piezoelectric micro-pump liquid cooling product, marking a breakthrough in domestic chip technology [1] - *ST Jiuyou received a decision from the Shanghai Stock Exchange to terminate its stock listing, which will transition to the national SME share transfer system [2] Group 2 - Hangzhou Garden plans to invest up to 450 million yuan to build a smart ecological design R&D headquarters [2] - Tiancheng Self-Control intends to invest 20 million yuan to establish a subsidiary [3] - Leidi Ke is acquiring a 30% stake in a partnership fund for 40 million yuan, indirectly holding 20% equity in Beifang Machinery [5] Group 3 - Jiangbolong's subsidiary signed a memorandum of cooperation with Sandisk to develop customized UFS products for the mobile and IoT markets [6] - Tongda Co. announced plans for its directors and executives to reduce their holdings by a total of 0.029% [7] - Yinlun Co.'s subsidiary completed the counseling acceptance for its public offering and listing on the Beijing Stock Exchange [8] Group 4 - Hongli Zhihui's controlling shareholder obtained a special loan of up to 45 million yuan for stock buyback [9] - Fengshan Group's shareholders plan to reduce their holdings by a total of 983,000 shares [11] - Kuai Ke Electronics' shareholder plans to reduce their holdings by up to 2% [13] Group 5 - Zhongdian Xinlong's director plans to reduce their holdings by up to 0.81% [15] - Maihe Co.'s shareholder intends to reduce their holdings by up to 1.5% [17] - Yuandao Communication's shareholder plans to reduce their holdings by up to 1.01% [19] Group 6 - Muyuan Co. submitted its H-share issuance application to the China Securities Regulatory Commission [21] - Jiechuang Intelligent won a police equipment procurement project worth 11.2362 million yuan [21] - Chongqing Steel signed an asset transfer contract worth 1.081 billion yuan with the Heavy Steel Group [22]

Key Points - The National Medical Products Administration plans to complete the review and approval of clinical trial applications for innovative drugs that meet requirements within 30 working days [4] - The U.S. and U.K. have reached a trade agreement, which includes a quota of 100,000 vehicles per year for U.S. imports from the U.K. with a 10% tariff rate [6] - The U.S. President Trump announced a temporary suspension of sanctions against Russia to facilitate negotiations [6] - The industrial added value in China increased by 5.8% year-on-year in May, while the retail sales of consumer goods reached 41,326 billion yuan, growing by 6.4% year-on-year [4] Company News - GAC Group denied rumors regarding employee stock ownership related to GAC Aion [9] - Midea Group plans to repurchase shares worth between 5 billion to 10 billion yuan [9] - Chongqing Steel signed an asset transfer contract worth 1.081 billion yuan with Chongqing Iron and Steel Group [9] - Muyuan Foods has submitted H-share filing materials to the China Securities Regulatory Commission [9] - Weir Group's stock name will change to "Haowei Group" starting June 20 [9] - LaKala is planning to issue H-shares and list on the Hong Kong Stock Exchange [9] - China Bank's Vice President Zhang Xiaodong has left due to job relocation [9] Industry Insights - CITIC Securities has received approval to issue up to 6 billion yuan in technology innovation bonds [10] - Huatai Securities has received registration approval from the CSRC for issuing up to 10 billion yuan in technology innovation corporate bonds [10] - Huatai Securities is optimistic about the home appliance sector, highlighting the strong demand for core assets and the potential for overseas market expansion [11] - CITIC Securities predicts a price increase of 5%-10% in the wind turbine sector by 2025, indicating a new profit recovery cycle for the industry [12]

江苏丰山集团股份有限公司 股东、董事兼高级管理人员减持股份计划公告 本公司董事会、全体董事及相关股东保证本公告内容不存在任何虚假记载、 误导性陈述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示： | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-038 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 1 15 个交易日后的 3 个月内，在符合法律法规规定的前提下，通过集中竞价交易 或大宗交易方式减持其所持有的公司股份合计不超过 169,000 股，减持数量占公 司总股本的比例不超过 0.10%，减持价格按照减持时的市场价格确定。 一、减持主体的基本情况 股东及董监高持股的基本情况 截至本公告日，江苏丰山集团股份有限公司（以下简称"公司"）股东顾翠 月女士持有公司股份 1,342,800 股，占公司股份总数的 0.81%，其一致行动人、 公司董事、常务副总裁陈亚峰先生持有公司股份 3,712,426 股，占公司股份总数 的 2.25%；公司董事、副总裁单永祥先生持有公司股份 1,256,108 股，占 ...

丰山集团（603810）公告，股东顾翠月女士拟自公告披露之日起15个交易日后的3个月内，通过集中竞 价交易或大宗交易方式减持不超过50万股，占公司总股本的0.30%。 ...

特此公告。 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"） 于 2024 年 6 月 26 日召 开第四届董事会第六次会议和第四届监事会第四次会议审议通过了《关于使用部 分闲置募集资金暂时补充流动资金的议案》，同意公司使用不超过 20,000 万元 的可转换公司债券闲置募集资金暂时补充流动资金（含全资子公司），使用期限 为自公司董事会审议通过之日起不超过 12 个月。具体内容详见公司于 2024 年 6 月 27 日在上海证券交易所网站（www.sse.com.cn）披露的《关于使用部分闲置 募集资金暂时补充流动资金的公告》（公告编号：2024-042）。 截至本公告披露日，公司已将上述用于暂时补充流动资金的可转换公司债券 闲置募集资金 1,600 万元提前归还至相应的募集资金专户，公司已不存在使用可 转换公司债券闲置募集资金暂时补充流动资金的情形。 公司已将上述募集资金归还情况通知了公司保荐机构华泰联合证券有限责 任公司及保荐代表人。 | 证券代码：603810 | 证券简称：丰 ...

截至本公告披露日，公司已将上述用于暂时补充流动资金的可转换公司债券 闲置募集资金 1,600 万元提前归还至相应的募集资金专户，公司已不存在使用可 转换公司债券闲置募集资金暂时补充流动资金的情形。 公司已将上述募集资金归还情况通知了公司保荐机构华泰联合证券有限责 任公司及保荐代表人。 特此公告。 江苏丰山集团股份有限公司董事会 2025 年 6 月 11 日 | 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-037 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于归还暂时用于补充流动资金的闲置募集资金的公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈述 或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 江苏丰山集团股份有限公司（以下简称"公司"） 于 2024 年 6 月 26 日召 开第四届董事会第六次会议和第四届监事会第四次会议审议通过了《关于使用部 分闲置募集资金暂时补充流动资金的议案》，同意公司使用不超过 20,000 万元 的可转换公司债券闲置募集资金暂 ...

江苏丰山集团股份有限公司（以下简称"公司"）于 2025 年 4 月 28 日召开 第四届董事会第十一次会议和第四届监事会第七次会议，于 2025 年 5 月 19 日召 开 2024 年年度股东大会审议通过了《关于 2025 年度公司使用闲置募集资金和自 有资金在非关联方机构进行现金管理的议案》，同意在确保不影响公司募投项目 建设、主营业务的正常开展、日常运营资金周转需要和资金安全的前提下，使用 不超过人民币 30,000 万元的公开发行可转换公司债券闲置募集资金进行现金管 理，用于投资安全性高、流动性好、发行主体有保本约定、单项产品期限最长不 超过十二个月的各种存款、理财产品或中国证监会认可的其他投资品种等（包括 但不限于结构性存款、定期存款、大额存单等产品）。现金管理额度自 2024 年 年度股东大会审议通过之日起 12 个月内有效，公司在上述额度内的资金可循环 滚动使用。具体内容详见公司于 2025 年 4 月 29 日在指定信息披露媒体披露的《关 于 2025 年度使用闲置募集资金和自有资金在非关联方机构进行现金管理的公告》 （公告编号：2025-020）。 一、公司募集资金现金管理产品专用结算账户 ...

Core Points - Jiangsu Fengshan Group Co., Ltd. has provided a guarantee of up to 100 million yuan for its subsidiary, Jiangsu Fengshan Biochemical Technology Co., Ltd. [1] - The total actual guarantee amount provided to Fengshan Biochemical has reached 162.26 million yuan [1] - The company has no collateral for this guarantee and has not experienced any overdue guarantees [1] Guarantee Overview - The guarantee is intended to meet the funding needs of Fengshan Biochemical, with a maximum guarantee amount of 100 million yuan established through a contract with Industrial and Commercial Bank of China [1][2] - The company plans to provide a total guarantee amount not exceeding 935 million yuan for the year 2025, which can be used in various forms such as guarantees, mortgages, and pledges [2] - The guarantee will be effective for 12 months from the approval date at the annual shareholders' meeting [2] Subsidiary Information - Jiangsu Fengshan Biochemical Technology Co., Ltd. is a wholly-owned subsidiary of Jiangsu Fengshan Group, established on October 14, 2022, with a registered capital of 100 million yuan [3][4] - The company engages in various activities including pesticide production, fertilizer production, and technology services [3][4] Financial Status of the Subsidiary - As of the announcement date, Fengshan Biochemical has total assets of approximately 1.60 billion yuan, total liabilities of about 710.35 million yuan, and net assets of approximately 894.46 million yuan [5] - The subsidiary reported an operating income of approximately 973.39 million yuan but incurred a net loss of about 7.58 million yuan [5] Necessity and Reasonableness of the Guarantee - The guarantee is deemed necessary to support the operational plans of Fengshan Biochemical, ensuring funding needs and enhancing decision-making efficiency [6] - The implementation of the guarantee is expected to facilitate the subsidiary's business operations and align with the long-term interests of the company [6] Board Opinion - The board has approved the proposal for the guarantee amount for the year 2025 [6] Cumulative Guarantee Amount - As of May 22, 2025, the total cumulative guarantee amount provided by the company for its subsidiaries is approximately 1.32 billion yuan, with an actual guarantee balance of about 186.03 million yuan [6]

| 证券代码：603810 | 证券简称：丰山集团 | 公告编号：2025-035 | | --- | --- | --- | | 转债代码：113649 | 转债简称：丰山转债 | | 江苏丰山集团股份有限公司 关于为全资子公司提供担保的进展公告 本公司董事会及全体董事保证本公告内容不存在任何虚假记载、误导性陈 述或者重大遗漏，并对其内容的真实性、准确性和完整性承担法律责任。 重要内容提示 ●被担保人名称：江苏丰山生化科技有限公司（以下简称"丰山生化"）， 系江苏丰山集团股份有限公司（以下简称"公司"）合并报表范围内子公司。 ● 本次担保额度及已实际为其提供的担保余额：本次担保最高额度为 10,000 万元，上述担保额度在 2024 年年度股东大会审议通过的对丰山生化担保预计的 93,500 万元额度内，无需另行召开董事会及股东大会审议。截至本公告披露日， 公司已实际为丰山生化提供的累计担保余额为 16,226.32 万元。 ●本次担保是否有反担保：无。 ●对外担保逾期的累计数量：无。 一、担保情况概述 （一）本次提供担保的具体情况 为满足丰山生化资金需要，近日，公司与中国工商银行股份有限公司盐城大 丰支行 ...